2018 was a incredible boom year in the number of new biotech offerings. Author explores the data around post-IPO market performance and the challenging end of year in the stock market.
Category: NASDAQ:ALLO
The Future Of Cancer Care: A 50 Minute Discussion At Forbes
The future of cancer therapy, an analysis of how Immunotherapy has improved oncology outcomes for patients. This year’s Forbes Summit highlighted both the difficulties, advancements and needs of the cancer care community in order to find the “cure” fo…
